Original Research

Published on 18 Mar 2021

Waterfall Forest Environment Regulates Chronic Stress via the NOX4/ROS/NF-κB Signaling Pathway

in Multiple Sclerosis and Neuroimmunology

Zixin Zhu
Xueke Zhao
Qiuyue OuYang
Yinghui Wang
Yan Xiong
Shuo Cong
Mingyu Zhou
Manman Zhang
Xinhua Luo
Mingliang Cheng

Frontiers in Neurology

doi 10.3389/fneur.2021.619728

3,991 views
10 citations

Study Protocol

Published on 18 Mar 2021

Telitacicept Following Plasma Exchange in the Treatment of Subjects With Recurrent NMOSD: Study Protocol for a Single-Center, Single-Arm, Open-Label Study

in Multiple Sclerosis and Neuroimmunology

Jie Ding
Yu Cai
Ye Deng
Xianguo Jiang
Meichun Gao
Yan Lin
Nan Zhao
Ze Wang
Haojun Yu
Wenwen Lv

Frontiers in Neurology

doi 10.3389/fneur.2021.596791

5,140 views
8 citations

Original Research

Published on 17 Mar 2021

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

in Multiple Sclerosis and Neuroimmunology

Jan Hillert
Melinda Magyari
Per Soelberg Sørensen
Helmut Butzkueven
Anneke Van Der Welt
Sandra Vukusic
Maria Trojano
Pietro Iaffaldano
Fabio Pellegrini
Robert Hyde

Frontiers in Neurology

doi 10.3389/fneur.2021.647811

7,996 views
10 citations

Brief Research Report

Published on 16 Mar 2021

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Emilio Portaccio
Angelo Bellinvia
Elio Prestipino
Benedetta Nacmias
Silvia Bagnoli
Lorenzo Razzolini
Luisa Pastò
Claudia Niccolai
Benedetta Goretti
Mattia Fonderico

Frontiers in Neurology

doi 10.3389/fneur.2021.645220

2,627 views
14 citations

Original Research

Published on 15 Mar 2021

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

in Multiple Sclerosis and Neuroimmunology

Zara A. Ioannides
Peter A. Csurhes
Nanette L. Douglas
Gem Mackenroth
Andrew Swayne
Kate M. Thompson
Tracey J. Hopkins
Kerryn A. Green
Stefan Blum
Kaye D. Hooper

Frontiers in Neurology

doi 10.3389/fneur.2021.652811

5,735 views
17 citations

Case Report

Published on 10 Mar 2021

A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review

in Multiple Sclerosis and Neuroimmunology

Mingming Li
Yue Zhang
Yujia Guan
Zunwei Zhang
Hanbing Dong
Yang Zhao
Hui Deng

Frontiers in Neurology

doi 10.3389/fneur.2021.621392

6,521 views
10 citations

Original Research

Published on 09 Mar 2021

Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort

in Multiple Sclerosis and Neuroimmunology

Zsófia Hayden
Beáta Bóné
Gergely Orsi
Monika Szots
Ferenc Nagy
Tünde Csépány
Zsolt Mezei
Cecília Rajda
Diána Simon
József Najbauer

Frontiers in Neurology

doi 10.3389/fneur.2021.611597

3,879 views
10 citations

Brief Research Report

Published on 08 Mar 2021

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

in Multiple Sclerosis and Neuroimmunology

Luca Bollo
Pietro Iaffaldano
Maddalena Ruggieri
Claudia Palazzo
Mariangela Mastrapasqua
Alessia Manni
Damiano Paolicelli
Antonio Frigeri
Maria Trojano

Frontiers in Neurology

doi 10.3389/fneur.2021.633115

3,385 views
4 citations

Systematic Review

Published on 08 Mar 2021

Effects of Transcranial Direct Current Stimulation on Cognition, Mood, Pain, and Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis

in Multiple Sclerosis and Neuroimmunology

Wan-Yu Hsu
Chia-Hsiung Cheng
Theodore P. Zanto
Adam Gazzaley
Riley M. Bove

Frontiers in Neurology

doi 10.3389/fneur.2021.626113

7,382 views
17 citations

Perspective

Published on 08 Mar 2021

Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM)

in Multiple Sclerosis and Neuroimmunology

João J. Cerqueira
Ana F. Ladeira
Ana M. Silva
Ângela Timóteo
José Vale
Lívia Sousa
Marta Arenga
Pedro Abreu
Rui Guerreiro
João de Sá

Frontiers in Neurology

doi 10.3389/fneur.2021.613769

3,493 views
5 citations

Original Research

Published on 05 Mar 2021

Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients

in Multiple Sclerosis and Neuroimmunology

Claudia Piervincenzi
Nikolaos Petsas
Laura De Giglio
Maurizio Carmellini
Costanza Giannì
Silvia Tommasin
Carlo Pozzilli
Patrizia Pantano

Frontiers in Neurology

doi 10.3389/fneur.2021.632917

2,499 views
3 citations

Original Research

Published on 03 Mar 2021

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients

in Multiple Sclerosis and Neuroimmunology

Tjalf Ziemssen
Holger Albrecht
Judith Haas
Luisa Klotz
Michael Lang
Christoph Lassek
Stephan Schmidt
Benjamin Ettle
Ulf Schulze-Topphoff

Frontiers in Neurology

doi 10.3389/fneur.2021.637107

3,224 views
5 citations

Original Research

Published on 03 Mar 2021

Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance

in Multiple Sclerosis and Neuroimmunology

Krisztián Kocsis
Nikoletta Szabó
Eszter Tóth
András Király
Péter Faragó
Bálint Kincses
Dániel Veréb
Bence Bozsik
Katalin Boross
Melinda Katona

Frontiers in Neurology

doi 10.3389/fneur.2021.619135

21,161 views
3 citations

Case Report

Published on 24 Feb 2021

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination

in Multiple Sclerosis and Neuroimmunology

Bing-Yan Ren
Yi Guo
Jing Han
Qian Wang
Zai-Wang Li

Frontiers in Neurology

doi 10.3389/fneur.2021.639265

3,077 views
10 citations

Original Research

Published on 24 Feb 2021

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study

in Multiple Sclerosis and Neuroimmunology

Wolfgang Köhler
Kirsten Bayer-Gersmann
Thomas Neußer
Markus Schürks
Tjalf Ziemssen

Frontiers in Neurology

doi 10.3389/fneur.2021.643126

2,965 views
6 citations

Mini Review

Published on 22 Feb 2021

The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge

in Multiple Sclerosis and Neuroimmunology

Iván Murrieta-Álvarez
Yahveth Cantero-Fortiz
Andrés A. León-Peña
Juan C. Olivares-Gazca
José Manuel Priesca-Marín
Guillermo J. Ruiz-Delgado
Andrés Gómez-De-León
Elías Eugenio Gonzalez-Lopez
José Carlos Jaime-Pérez
David Gómez-Almaguer

Frontiers in Neurology

doi 10.3389/fneur.2021.647425

8,300 views
15 citations

Navigation group

Articles

Waterfall Forest Environment Regulates Chronic Stress via the NOX4/ROS/NF-κB Signaling Pathway

Telitacicept Following Plasma Exchange in the Treatment of Subjects With Recurrent NMOSD: Study Protocol for a Single-Center, Single-Arm, Open-Label Study

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review

Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

Effects of Transcranial Direct Current Stimulation on Cognition, Mood, Pain, and Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis

Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM)

Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients

Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study

The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge